相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats
Gokhan Unal et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Curcumin phytosome modulates aluminum-induced hepatotoxicity via regulation of antioxidant, Bcl-2, and caspase-3 in rats
Mohammed Al-Kahtani et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Preventive effect of silymarin-loaded chitosan nanoparticles against global cerebral ischemia/reperfusion injury in rats
Akbar Hajizadeh Moghaddam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naive Schizophrenia Patients
Xiang Zhou et al.
FRONTIERS IN NEUROSCIENCE (2020)
Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia
Samskruthi Madireddy et al.
BRAIN SCIENCES (2020)
Protective Effects of Curcumin and its Nano-Phytosome on Carrageenan-Induced Inflammation in Mice Model: Behavioral and Biochemical Responses
Saeideh Baradaran et al.
JOURNAL OF INFLAMMATION RESEARCH (2020)
Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)
D. Briskey et al.
EUROPEAN JOURNAL OF NUTRITION (2019)
Subchronic ketamine alters behaviour, metabolic indices and brain morphology in adolescent rats: Involvement of oxidative stress, glutamate toxicity and caspase-3-mediated apoptosis
A. Y. Onaolapo et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2019)
Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats
Mehrez E. El-Naggar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia
Dag K. Solberg et al.
ACTA NEUROPSYCHIATRICA (2019)
Curcumin Effects on Memory Impairment and Restoration of Irregular Neuronal Distribution in the Hippocampal CA1 Region After Global Cerebral Ischemia in Male Rats
Leila Kamali Dolatabadi et al.
BASIC AND CLINICAL NEUROSCIENCE (2019)
Protective effects of Spinacia oleracea seeds extract in an experimental model of schizophrenia: Possible behavior, biochemical, neurochemical and cellular alterations
Monu Yadav et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways
Benneth Ben-Azu et al.
BRAIN RESEARCH BULLETIN (2018)
Nanosized soy phytosome-based thermogel as topical anti-obesity formulation: an approach for acceptable level of evidence of an effective novel herbal weight loss product
Shahira F. El-Menshawe et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum
Reza Naeimi et al.
NEUROSCIENCE LETTERS (2018)
Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway
Hebatalla I. Ahmed et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)
Curcumin Protects Against Chronic Stress-induced Dysregulation of Neuroplasticity and Depression-like Behaviors via Suppressing IL-1 beta Pathway in Rats
Cuiqin Fan et al.
NEUROSCIENCE (2018)
Using Phytochemicals to Investigate the Activation of Nicotine Detoxification via Upregulation of CYP2A6 in Animal Models Exposed Tobacco Smoke Condensate by Intratracheal Instillation
Dayeon Lee et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Prenatal exposure to ketamine in rats: Implications on animal models of schizophrenia
Carlos M. Coronel-Oliveros et al.
DEVELOPMENTAL PSYCHOBIOLOGY (2018)
Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin
S. Koellner et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy
Mona Hashemian et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy
Olakunle James Onaolapo et al.
PSYCHOPHARMACOLOGY (2017)
Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer's type
Taysa B. Bassani et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Disturbances of novel object exploration and recognition in a chronic ketamine mouse model of schizophrenia
Maria Jelena Hauser et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin
R. Nazari-Vanani et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo
Yuhui Chen et al.
DRUG DELIVERY (2016)
Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine
Alexandra I. Zugno et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice
Benneth Ben-Azu et al.
PHARMACEUTICAL BIOLOGY (2016)
Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users
Ni Fan et al.
PSYCHIATRY RESEARCH (2016)
Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
Ludmyla Kandratavicius et al.
BMC NEUROSCIENCE (2015)
The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration
Zhen Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats
Marta Gazal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
W. Zhou et al.
EUROPEAN PSYCHIATRY (2014)
Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow et al.
BIOLOGICAL PSYCHIATRY (2013)
Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
Gianluca Serafini et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice
Kailash M. Choudhary et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways
Aline Santos Monte et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Free and nanoencapsulated curcumin prevents cigarette smoke-induced cognitive impairment and redox imbalance
Jeandre Augusto dos Santos Jaques et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2013)
Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study
Yakup Albayrak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice
Yue Hou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia
Ben A. Chindo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: Implications for experimental psychosis
Manavi Chatterjee et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Hepatoprotective effect of curcumin in lipopolysaccharide/D-galactosamine model of liver injury in rats: Relationship to HO-1/CO antioxidant system
Dalibor Cerny et al.
FITOTERAPIA (2011)
Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation
John Cuomo et al.
JOURNAL OF NATURAL PRODUCTS (2011)
5HT1A and 5HT1B receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats
Jalal Solati et al.
NEUROSCIENCE LETTERS (2011)
GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice
Neeraj Gilhotra et al.
BRAIN RESEARCH (2010)
Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
Francisca Charliane Carlos da Silva et al.
BRAIN RESEARCH BULLETIN (2010)
Supramolecular phospholipids-polyphenolics interactions: The PHYTOSOME® strategy to improve the bioavailability of phytochemicals
Ajay Semalty et al.
FITOTERAPIA (2010)
Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model
Jogender Mehla et al.
LIFE SCIENCES (2010)
Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats
K. H. Reeta et al.
BRAIN RESEARCH (2009)
Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade
Teresa Marie du Bois et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats
Larissa de Oliveira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
Timothy H. Marczylo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Oxidative stress reduces renal dopamine D1 receptor-Gq/11α G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2
Anees Ahmad Banday et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats
Kuntal Maiti et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
A Becker et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues:: Effect of vanadate and fenugreek (Trigonella foenum graecum)
S Genet et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
LS Kegeles et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
